The Ensign Group, Inc. (ENSG) — ESG & Values Scores

Environment story

Ensign discloses a modest environmental management framework centered on facility modernization, utility optimization, and governance via an Environmental Management Team. However, the company provides no quantified Scope 1, Scope 2, or Scope 3 emissions data, no renewable electricity percentage, and no net-zero target year. The 10-K states $193.6M was spent on facility improvements in 2025, including solar and HVAC upgrades, but lacks specificity on carbon impact or decarbonization progress. The company acknowledges climate transition and physical risks under TCFD but does not disclose baseline emissions or measurable reduction targets. Without verified emissions baselines and reduction commitments, claims of environmental progress remain largely qualitative and unauditable.

Criticisms on file

No material criticisms on file for this pillar.

Disclosed initiatives

Facility Modernization Program

Annual capital expenditure of $193.6M (2025) on property improvements including solar projects, HVAC upgrades, water systems, LED lighting retrofits and utility optimization.

Targets reduction of electricity usage and carbon emissions; tracking through energy management systems and ENERGY STAR scores, but no baseline or target metrics disclosed.
Environmental Management Team (EMT)

Cross-functional governance structure led by Service Center leadership, responsible for environmental policy, climate risk identification under TCFD, and advising field operators on capital project priorities.

Monitors environmental metrics and develops reduction targets; no specific targets or timelines disclosed in 10-K.

Social story

Ensign reports ~46,000 FTE employees and emphasizes culture, training, compensation, and charitable giving through Elevate Charities and Insignia Pathway. The company discloses no CEO-to-median-worker pay ratio, no detailed workforce diversity metrics (gender/racial representation in workforce or leadership), and no turnover rate. Union standing is mentioned only obliquely in Risk Factors, citing past negative publicity campaigns by national labor unions but providing no current labor relations data, NLRB complaints, or formal union-suppression documentation. Staffing mandates and turnover metrics are driven by state regulations and acuity needs, but quantified baseline data is absent. The company claims commitment to inclusion and equal opportunity but does not provide EEO-1 disclosure, pay equity audits, or third-party diversity certifications (e.g., HRC CEI).

Criticisms on file

Past labor union negative publicity campaigns
Source: ENSG 10-K Risk Factors: 'The actions of a national labor union that has pursued a negative publicity campaign criticizing our business in the past may adversely affect our revenue and our profitability.'

Disclosed initiatives

CEO-in-Training and COO Programs

Rigorous internal development programs (70–80 prospective administrators in training; exceeds state mandates of 1,000 hours). Focus on clinical and operational leadership development.

Supports talent retention and succession planning; enables acquisition integration and facility improvement, but no diversity targets specified.
Elevate Charities Partnership

Multi-fund structure: Heritage Fund (direct support to seniors), Heritage Scholarship Fund (332 scholarships awarded since 2018 to advance clinical professionals in long-term care), and Emergency Fund (89% of subsidiary employees contributed in 2025).

Supports workforce development and employee hardship relief; creates pathways for economically disadvantaged clinical staff.
Insignia Pathway Charitable Initiative

Formed 2024; awarded >$1.0M in grants to RNs from 23 countries committed to U.S. skilled nursing providers; aims to expand post-acute care workforce.

Addresses nursing shortage and international talent pipeline; supports workforce expansion and retention.

Governance story

Ensign operates as a holding company with a REIT subsidiary (Standard Bearer) and decentralized operational structure via independent subsidiaries. The 10-K discloses no board independence percentage, no dual-class share structure data, and no lobbying expenditure amounts. Risk Factors acknowledge conflicts of interest: certain directors serve on both Ensign and Pennant (another healthcare REIT) boards, with potential ownership overlap. Governance focuses on compliance, regulatory monitoring, and quality improvement but lacks transparency on board composition, executive compensation ratios, and lobbying activity. The company faces active regulatory scrutiny (OIG audits, CMS surveys, Special Focus Facility oversight) and mentions ongoing California OHCA antitrust investigation (initiated March–September 2025; subpoena issued October 10, 2025; company filed constitutional challenge in Superior Court). No active shareholder derivative litigation or major SEC enforcement proceedings disclosed, but regulatory compliance risk is material and ongoing.

Criticisms on file

California Office of Health Care Affordability (OHCA) antitrust investigation and regulatory subpoena
Source: ENSG 10-K, Risk Factors and Government Regulation: 'Between March and September 2025, we provided OHCA with requested information regarding specific components of a proposed transaction. Despite our ongoing cooperation, on October 10, 2025, OHCA issued an investigatory subpoena to us to produce (among other things) certain confidential and proprietary documents... We have filed a Petition in the Superior Court of the State of California, County of Orange, seeking a declaration that the CMIR regulations violate the United States Constitution and/or the California Constitution.'
Ongoing OIG and CMS regulatory scrutiny and audit risk
Source: ENSG 10-K Risk Factors and Government Regulation: Multiple references to OIG audits of nursing home staffing hours, Part D billing, medical director engagement, and ownership changes; CMS enforcement actions including Special Focus Facility program; state survey agency enforcement.
Potential conflict of interest: directors serving on both Ensign and Pennant boards
Source: ENSG 10-K Risk Factors: 'Certain directors who serve on our Board of Directors also serve as directors of Pennant, and ownership of shares of Pennant common stock by our directors and executive officers may create, or appear to create, conflicts of interest.'

Disclosed initiatives

Compliance Monitoring and Internal Audits

Regular internal investigations into care delivery, recordkeeping, and billing processes of independent subsidiaries; proactive corrective action to detect and remedy noncompliance.

Intended to mitigate fraud, billing errors, and regulatory deficiency risk; efforts to correct noncompliance may temporarily reduce revenue.
Environmental, Social, and Governance Committee

Multi-disciplinary governance committee overseeing ESG strategy, including environmental management, quality of care, regulatory compliance, and social sustainability initiatives.

Provides structured oversight of material ESG risks and mitigation efforts; reports ESG metrics and initiatives on company website.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of The Ensign Group, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open The Ensign Group, Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)